According to the latest data from the Hong Kong Stock Exchange, on June 4, E Fund Management Co., Ltd. increased its holding in Biocytogen-B (02315) by 207,000 shares. The purchase price was approximately HK$40.6298 per share, resulting in a total investment of around HK$8.4104 million.
Following this transaction, the fund's total shareholding in the company has risen to 5.736 million shares. This represents a stake of 5.18% in the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments